Loading...
•
Jun 30, 2023
Pediatrix Q2 2023 Earnings Report
Reported earnings from continuing operations and net revenue that were in line with expectations, reflecting stable patient volumes and strong cash generation.
Key Takeaways
Pediatrix Medical Group reported second-quarter earnings from continuing operations of $0.34 per share, with an adjusted EPS of $0.39. Net revenue was $500.6 million, compared to $486.0 million for the prior-year period. The company's overall same-unit revenue increased by 3.2 percent.
Net revenue for the second quarter was $500.6 million, compared to $486.0 million for the prior year period.
Income from continuing operations was $28.3 million, or $0.34 per diluted share.
Adjusted EBITDA from continuing operations was $59.1 million, compared to $65.6 million for the prior-year period.
Same-unit revenue increased by 3.2 percent, driven by net reimbursement-related factors and patient volume.
Forward Guidance
Pediatrix anticipates that its 2023 Adjusted EBITDA will be in a range of $235 million to $245 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...